Half-life-extended Monoclonal Antibody APG777 for Atopic Dermatitis: Design of the Phase 2 APEX Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s456, 2024. DOI: 10.25251/skin.8.supp.456. Disponível em: https://skin.dermsquared.com/skin/article/view/3074. Acesso em: 18 may. 2025.